• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

撤稿：甲磺酸阿帕替尼片联合紫杉醇同步放化疗一线治疗局部晚期鼻咽癌的临床疗效

Retracted: Clinical Effect of Apatinib Mesylate Tablets Combined with Paclitaxel Concurrent Radiotherapy and Chemotherapy in the First-Line Treatment of Locally Advanced Nasopharyngeal Carcinoma.

作者信息

International Emergency Medicine

出版信息

Emerg Med Int. 2024 Jan 24;2024:9795276. doi: 10.1155/2024/9795276. eCollection 2024.

DOI:10.1155/2024/9795276
PMID:38298972
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10830282/
Abstract

[This retracts the article DOI: 10.1155/2022/6293816.].

摘要

[本文撤回文章DOI: 10.1155/2022/6293816。]

相似文献

1
Retracted: Clinical Effect of Apatinib Mesylate Tablets Combined with Paclitaxel Concurrent Radiotherapy and Chemotherapy in the First-Line Treatment of Locally Advanced Nasopharyngeal Carcinoma.撤稿：甲磺酸阿帕替尼片联合紫杉醇同步放化疗一线治疗局部晚期鼻咽癌的临床疗效
Emerg Med Int. 2024 Jan 24;2024:9795276. doi: 10.1155/2024/9795276. eCollection 2024.
2
Clinical Effect of Apatinib Mesylate Tablets Combined with Paclitaxel Concurrent Radiotherapy and Chemotherapy in the First-Line Treatment of Locally Advanced Nasopharyngeal Carcinoma.甲磺酸阿帕替尼片联合紫杉醇同步放化疗一线治疗局部晚期鼻咽癌的临床疗效
Emerg Med Int. 2022 Aug 11;2022:6293816. doi: 10.1155/2022/6293816. eCollection 2022.
3
Weekly paclitaxel with concurrent radiotherapy followed by adjuvant chemotherapy in locally advanced nasopharyngeal carcinoma.每周紫杉醇联合同期放疗序贯辅助化疗治疗局部晚期鼻咽癌。
Radiother Oncol. 2009 Dec;93(3):488-91. doi: 10.1016/j.radonc.2009.06.030. Epub 2009 Aug 11.
4
Apatinib combined with chemotherapy or concurrent chemo-brachytherapy in patients with recurrent or advanced cervical cancer: A phase 2, randomized controlled, prospective study.阿帕替尼联合化疗或同步放化疗治疗复发性或晚期宫颈癌患者：一项2期随机对照前瞻性研究。
Medicine (Baltimore). 2020 Mar;99(11):e19372. doi: 10.1097/MD.0000000000019372.
5
Phase II clinical trial using camrelizumab combined with apatinib and chemotherapy as the first-line treatment of advanced esophageal squamous cell carcinoma.卡瑞利珠单抗联合阿帕替尼和化疗一线治疗晚期食管鳞癌的 II 期临床试验。
Cancer Commun (Lond). 2020 Dec;40(12):711-720. doi: 10.1002/cac2.12119. Epub 2020 Dec 12.
6
Apatinib Combined with Paclitaxel and Cisplatin Neoadjuvant Chemotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma.阿帕替尼联合紫杉醇和顺铂新辅助化疗治疗局部晚期食管鳞癌。
Cancer Biother Radiopharm. 2022 May;37(4):324-331. doi: 10.1089/cbr.2021.0086. Epub 2021 Sep 15.
7
Retrospective Analysis of Induction Chemotherapy plus Concurrent Chemoradiotherapy under Intensity-Modulated Radiotherapy Mode for Locally Advanced Nasopharyngeal Carcinoma.局部晚期鼻咽癌调强放疗模式下诱导化疗加同期放化疗的回顾性分析。
Oncol Res Treat. 2021;44(11):602-612. doi: 10.1159/000519278. Epub 2021 Oct 1.
8
Paclitaxel with cisplatin in concurrent chemoradiotherapy for locally advanced nasopharyngeal carcinoma.紫杉醇联合顺铂同期放化疗治疗局部晚期鼻咽癌。
Eur Arch Otorhinolaryngol. 2010 May;267(5):773-8. doi: 10.1007/s00405-009-1112-7. Epub 2009 Oct 10.
9
Apatinib mesylate tablet in the treatment of advanced malignant melanoma.甲磺酸阿帕替尼片治疗晚期恶性黑色素瘤
Onco Targets Ther. 2018 Aug 31;11:5333-5338. doi: 10.2147/OTT.S175507. eCollection 2018.
10
Induction chemotherapy with paclitaxel and cisplatin, followed by concomitant cisplatin and radiotherapy for the treatment of locally advanced nasopharyngeal carcinoma.采用紫杉醇和顺铂进行诱导化疗，随后采用顺铂同步放疗治疗局部晚期鼻咽癌。
J Egypt Natl Canc Inst. 2006 Dec;18(4):348-56.

本文引用的文献

1
Clinical Effect of Apatinib Mesylate Tablets Combined with Paclitaxel Concurrent Radiotherapy and Chemotherapy in the First-Line Treatment of Locally Advanced Nasopharyngeal Carcinoma.甲磺酸阿帕替尼片联合紫杉醇同步放化疗一线治疗局部晚期鼻咽癌的临床疗效
Emerg Med Int. 2022 Aug 11;2022:6293816. doi: 10.1155/2022/6293816. eCollection 2022.